BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14

• Press Releases

  Ascletis Announces Initiation of Global Phase III for Oral Small Molecule GLP-1, ASC30 and Positive Preclinical Data for Its First-in-Class Oral Small Molecule GLP-1/GIP/Amylin Fixed-Dose Combination

  August 3, 2026

   · 

  9 min read
• Press Releases

  Biocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron’s Eylea® 2 mg

  August 3, 2026

   · 

  6 min read
• Press Releases

  Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results

  August 3, 2026

   · 

  2 min read
• Press Releases

  Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

  August 3, 2026

   · 

  13 min read
• Press Releases

  Korsana Biosciences Strengthens Leadership with Executive and Board Appointments to Support Next Phase of Growth

  August 3, 2026

   · 

  11 min read
• Press Releases

  U.S. FDA Grants Orphan Drug Designation to Zai Lab’s DLL3-Targeting ADC Zocilurtatug Pelitecan (Zoci) for the Treatment of Neuroendocrine Carcinomas (NECs)

  August 3, 2026

   · 

  5 min read
• Press Releases

  Rocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease

  August 3, 2026

   · 

  7 min read
• Press Releases

  Curium Announces Definitive Agreement to Merge with Lantheus

  August 3, 2026

   · 

  21 min read
• Press Releases

  Helus Pharma Appoints Michael Halstead as Chief Executive Officer

  August 3, 2026

   · 

  8 min read
• Press Releases

  ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results

  August 3, 2026

   · 

  1 min read